Our case report presents one of the rarely seen disorders L-2-hydroxyglutaric aciduria. Very little information is given in the literature and it remained undiagnosed until the 1980s. According to our information, only 295 events have been described in the literature till date. Our case report describes the disease manifestations, clinical pictures, and a review of the relevant literature on L-2-hydroxyglutaric aciduria. Our patients were females aged 12 and 13 years, respectively, which were born in consanguineous and Caucasian descent family.
L-2-hydroxyglutaric aciduria belongs to the group of organic acidurias. L-2-hydroxyglutaric aciduria is an inherited, autosomal recessive disease and has a slow-progressing disease pattern. Prominent clinical features in our patients were febrile seizures, generalized seizures, mental retardation, and speech difficulties. We confirmed the diagnosis by characteristic brain magnetic resonance imaging (MRI) findings and laboratory tests.
A 13-year-old girl presented to the emergency department with a generalized seizure. After pediatric and neurological evaluation, the patient showed mental retardation, cognitive impairment, speech difficulties, and ataxia. Magnetic resonance imaging (MRI) and computed tomography (CT) findings showed diffuse lesions in subcortical white matter with spared deep white matter, basal ganglia, and brainstem (Figure 1, Figure 2, Figure 3). Cerebellar vermis and dentate nuclei involvement was seen (Figure 2a). After contrast administration, no significant change was detected in MR sequences.
The first episode manifested as a febrile seizure at 7 days of age, resolving with antipyretics. Delayed milestones were observed from 2 years of age. The first pronounced cognitive impairment was onset at 9 years of age after an upper respiratory viral infection when the patient came to the emergency department with a febrile seizure. Further investigations revealed that her sibling, a 12 years old girl had prominent mental retardation and generalized seizures episodes. Specific MRI findings confirmed the diagnosis (Figure 5) and increased L-2-hydroxyglutaric acid (L-2-HGA) levels in urine and blood. Parents and their 5 years old son were disease-free. Additional family history includes Caucasian descent, consanguineous marriage, uneventful pregnancy, and normal root of delivery for all the children.
Initially, L-2-HGA was described and characterized by Duran, Barth, and their colleagues as a rare autosomal recessive organic aciduria affecting only the central nervous system, manifesting itself with specific MRI changes 1, 2.
Despite the first report on L-2-HGA in 1980, a total of 295 cases have been reported worldwide in the literature 3, 4.
L and D isoforms of 2-HGA can be found in the urine in equal amounts in healthy individuals. An increase of any isoform (L-D) configurations is a sign of potential disease. Progression of disease in L-2-HGA is slow, however, D-2-HGA among neonates may present prominently and with severe manifestations 5, 6, 7.
The pathogenesis of L2HGA is uncertain, and the accumulation of L-2-Hydroxyglutarate (L-2-HG) damages white matter 8, 9. MR spectroscopy shows a decrease in the neuronal N-acetyl aspartate (NAA) and choline and increases the Myo-inositol peaks 10. The myo-inositol peaks, which is a precursor of phosphatidylinositol, suggest inhibition of phosphatidylinositol synthesis, whereas the reduction of choline may reflect a progressive stage of neurodegeneration 10.
A definitive diagnosis depends on characteristic MRI findings, which include scattered or diffuse subcortical white-matter abnormalities that fade centripetally and detection of increased L-2 HGA levels in the urine, blood, and cerebrospinal fluid 5, 11, 12, 13, 14, 15.
Differential diagnosis with other similar diseases also plays an important role in making a diagnosis. MRI manifestations of Canavan diseases have also similar findings as noted in L-2-HGA. In L-2-HGA white matter the cortical region is more involved than the periventricular. This is one of the main differences between L-2-HGA from other leukodystrophies. In addition to subcortical cerebral white matter abnormalities, L-2-HGA and Canavan disease mainly cause symmetrical hyperintensity in the dentate nuclei. However, Canavan disease affects the brainstem, whereas L-2-HGA does not 12.
In L-2-HGA, the symptoms like mental retardation, cognitive impairment, ataxia, and macrocephaly are presented at a young age. At older ages, walking disorder which manifests as ataxia and decreased IQ levels are more prominent signs 5, 16. Some studies mention that before 10 years of age IQ levels of patients were between 50 and 75 17. Patients who have a late onset of disease compared to patients whose disease manifestations occur earlier have milder clinical manifestations 16.
In our case, the older sibling presented cognitive symptoms at age 9, and the younger sibling developed cognitive regression earlier (4 years). However, no macrocephaly was observed in both sisters.
Some studies in the literature suggest that epileptic seizures or even status epilepticus may occur in the early stages of L-2-HGA. This is probably due to early subcortical white matter changes with the subsequent development of epilepsy. Febrile seizures partial and major seizures have been reported and are generally difficult to control 5, 11, 12, 13.
In our cases, the first alarming sign was a febrile seizure that occurred before the generalized seizure. Although febrile seizures are not considered a risk factor for grand mal, we consider that as lesion areas enlarge, the magnitude of seizure expands.
Previously Mediterranean origin of the disorder was mentioned in the literature, additional surveys conducted all in Turkey, that included haplotype and mutation analyses of families, revealed nine different mutations which excluded a founder effect 13, 17.
Regarding the study that we came across in the library, 18 families were selected for evaluation. They were from rural areas of Turkey in Central and South-East Anatolia. Consanguinity was known in 17 families. A total of 89 individuals including 28 affected subjects (15 males and 13 females) were analyzed. The mean age at the time of diagnosis was 13.4 years (2.5 –32 years) 17.
One of the retrospective study studies evaluated MRI findings of L-2 HGA among 17 patients, and also described sibling patients. The author relates the severity of clinical symptoms with the severity of MRI findings, but atrophy of white matter is related to the duration of the disease 18. In another study along with 8 patients which also included siblings despite both patients’ speech difficulties being onset at an early age, walking difficulties and ataxia started later years of age. And the same study mentions that these patients can walk without support before they lost of walking ability 19.
An Our patients were same age range when the disease is diagnosed. Clinical symptoms were similar, except for prominent mental retardation in 13 years old patients started at 9 years of age but in younger 12 years old patients at 5 years of age with prominent speech difficulties, and cognitive impairment. Also, ataxia and walking difficulties were only noticed after neurologic evaluation which was unrecognized by parents. Regarding family history, a recent paper about Pakistani siblings with l-2-hydroxyglutaric which also was born from consanguineous parents, with a similar clinical picture as our patients, mentions mental regression and seizures in both patients of patients 20. But in our case, after neurologic evaluation of mental deterioration, cognitive impairment, and speech difficulty was seen in neither parent.
Reaching more patients reaches adulthood, studies mention an increased incidence of brain tumors in the late years of age were observed 21, 22, 23. This feature of L-2-hydroxyglutaric aciduria also makes it important to diagnose and evaluate.
Our cases were a few among the rare autosomal-recessive and inherited neurometabolic disorders. A high index of suspicion should be noted from childhood as evidenced by delayed milestones, psychomotor retardation, speech difficulties, spasticity, and seizures.
Our observations and previous studies in the literature frequently mentioned Caucasian, and Meditteranean populations being increasingly affected by the disease. Also, consanguineous families carry a high risk of developing L-2-HGA.
Also increased incidence of brain tumors in this population requires frequent follow-up of patients.
The authors state that there is no conflict of interest.
The consent form was filled out by the parents of participants.
CT- Computed Tomography
MRI- Magnetic Resonance Imaging
NAA - Neuronal N-acetyl aspartate
L-2-HGA - L-2-hydroxyglutaric aciduria
[1] | Barth P.G., Hoffmann G.F., Jaeken J., et al. L-2-hydroxyglutaric acidemia: a novel inherited neurometabolic disease. Ann Neurol 1992; 32: 66-71. | ||
In article | View Article PubMed | ||
[2] | Duran M., Kamerling J.P, Bakker H.D, van Gennip A.H, Wadman S.K. L-2-hydroxyglutaric aciduria: an inborn error of metabolism? J Inherit Metab. Dis. 1980; 3: 109-112. | ||
In article | View Article PubMed | ||
[3] | George J., Sandhya P., Sajitha K.V, et al. Attention deficit hyperactivity disorder: a rare clinical presentation of L-2-hydroxyglutaric aciduria. BMJ Case Reports CP 2021; 14: e244038. | ||
In article | View Article PubMed | ||
[4] | Chaudhari D.M, Renjen P.N, Goyal N., et al. Central variant reversible encephalopathy syndrome BMJ Case Reports C.P 2022; 15: e245636. | ||
In article | View Article PubMed | ||
[5] | Topçu M, Aydin O.F, Yalçinkaya C., et al. L-2-hydroxyglutaric aciduria: a report of 29 patients. Turk J. Pediatr 2005; 47: 1-7. | ||
In article | |||
[6] | Moroni I., D’Incerti L., Farina L., et al. Clinical, biochemical and neuroradiological findings in L-2-hydroxyglutaric aciduria. Neurol Sci 2000; 21: 103-8. | ||
In article | View Article PubMed | ||
[7] | Haliloglu G., Jobard F., Oguz K.K, et al. L-2-hydroxyglutaric aciduria and brain tumors in children with mutations in the L2HGDH gene: neuroimaging findings. Neuropediatrics 2008; 39: 119-22. | ||
In article | View Article PubMed | ||
[8] | Latini A., Scussiato K., Borba Rosa R., et al. Induction of oxidative stress by L-2-hydroxyglutaric acid in rat brain. J. Neurosci Res. 2003; 74: 103-110. | ||
In article | View Article PubMed | ||
[9] | Ullah M.I., Nasir A., Ahmad A., et al. Identification of novel L2HGDH mutation in a large consanguineous Pakistani family—a case report. BMC Med. Genet. 2018; 19: 25. | ||
In article | View Article PubMed | ||
[10] | Hanefeld F., Kruse B., Bruhn H. and Frahm J. (1994). In vivo proton magnetic resonance spectroscopy of the brain in a patient with L-2-hydroxyglutaric acidemia. Pediatr. Res., 35, 614-616. | ||
In article | View Article | ||
[11] | Mete A., Isikay S., Sirikci A., et al. Eyelid myoclonia with absence seizures in a child with l-2 hydroxyglutaric aciduria: findings of magnetic resonance imaging. Pediatr Neurol 2012; 46: 195-7. | ||
In article | View Article PubMed | ||
[12] | Topçu M., Erdem G., Saatçi I., et al. Clinical and magnetic resonance imaging features of L-2-hydroxyglutaric acidemia: report of three cases in comparison with Canavan disease. J.Child Neurol 1996; 11: 373-7. | ||
In article | View Article PubMed | ||
[13] | Zafeiriou D.I, Sewellb A., Savvopoulou-Augoustidoua P., Gombakisa N., Katzoset G. L-2-Hydroxyglutaric aciduria presenting as status epilepticus. Brain Dev. 2001; 23(4):255-7. | ||
In article | View Article | ||
[14] | Moroni I., D’Incerti L., Farina L., et al. Clinical, biochemical and neuroradiological findings in L-2-hydroxyglutaric aciduria. Neurol Sci 2000; 21: 103-8. | ||
In article | View Article PubMed | ||
[15] | Karatas H., Saygi S., Bastan B. L-2-hydroxyglutaric aciduria. Report of four Turkish adult patients. Neurologist. 2010; 16: 44-6. | ||
In article | View Article PubMed | ||
[16] | Fujitake J., Ishikawa Y., Fujii H., et al. L-2-hydroxyglutaric aciduria: two Japanese adult cases in one family. J.Neurol 1999; 246: 378-382. | ||
In article | View Article PubMed | ||
[17] | Meral Topçu., Florence Jobard., Sophie Halliez., Turgay Coskun, Cengiz Yalçinkayal, Filiz Ozbas Gerceker, Ronald J.A. Wanders, Jean-François Prud'homme, Mark Lathrop, Meral Özguc, Judith Fischer, L-2-Hydroxyglutaric aciduria: identification of a mutant gene C14orf160, localized on chromosome 14q22.1, Human Molecular Genetics, Volume 13, Issue 22, 15 November 2004, Pages 2803-2811. | ||
In article | View Article PubMed | ||
[18] | Héla Fourati, Emna Ellouze, Mourad Ahmadi, Dhouha Chaari, Fatma Kamoun, Ines Hsairi, Chahnez Triki, Zeineb Mnif, MRI features in 17 patients with l2 hydroxyglutaric aciduria, European Journal of Radiology Open,Volume 3,2016,Pages 245-250, ISSN 2352-0477. | ||
In article | View Article PubMed | ||
[19] | Canda, Ebru & Kose, Melis & Yazıcı, Havva & Er, Esra & Eraslan, Cenk & Ucar, Sema & Habif, Sara & Karaca, Emin & Onay, Hüseyin & Ozkinay, Ferda & Coker, Mahmut. (2018). Clinical, Neuroimaging, And Genetic Features of Patients With L-2-Hydroxyglutaric Aciduria. The Journal of Pediatric Research. 5. 10.4274/jpr.59454. | ||
In article | View Article | ||
[20] | László Sztriha, Aithala Gururaj, Peter Vreken, Michael Nork, Gilles G Lestringant,l-2-hydroxyglutaric aciduria in two siblings,Pediatric Neurology,Volume 27, Issue 2, 2002, Pages 141-144. | ||
In article | View Article | ||
[21] | Aghili 1, Zahedi F, Rafiee E. Hydroxyglutaric aciduria and malignant brain tumor: a case report and literature review. J Neurooncol 2009; 91: 233-6. | ||
In article | View Article PubMed | ||
[22] | Haliloglu G, Jobard F, Oguz KK, et al. L-2-hydroxyglutaric aciduria and brain tumors in children with mutations in the L2HGDH gene: neuroimaging findings. Neuropediatrics 2008; 39: 119-22. | ||
In article | View Article PubMed | ||
[23] | Moroni I, Bugiani M, D’Incerti L, et al. L-2-hydroxyglutaric aciduria and brain malignant tumors: a predisposing condition? Neurology 2004; 62: 1882-4. | ||
In article | View Article PubMed | ||
Published with license by Science and Education Publishing, Copyright © 2022 Rasim Bakhtiyar Bayramov, Mehriban Musa Sariyeva and Narmin Eldar Maharramli
This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/
[1] | Barth P.G., Hoffmann G.F., Jaeken J., et al. L-2-hydroxyglutaric acidemia: a novel inherited neurometabolic disease. Ann Neurol 1992; 32: 66-71. | ||
In article | View Article PubMed | ||
[2] | Duran M., Kamerling J.P, Bakker H.D, van Gennip A.H, Wadman S.K. L-2-hydroxyglutaric aciduria: an inborn error of metabolism? J Inherit Metab. Dis. 1980; 3: 109-112. | ||
In article | View Article PubMed | ||
[3] | George J., Sandhya P., Sajitha K.V, et al. Attention deficit hyperactivity disorder: a rare clinical presentation of L-2-hydroxyglutaric aciduria. BMJ Case Reports CP 2021; 14: e244038. | ||
In article | View Article PubMed | ||
[4] | Chaudhari D.M, Renjen P.N, Goyal N., et al. Central variant reversible encephalopathy syndrome BMJ Case Reports C.P 2022; 15: e245636. | ||
In article | View Article PubMed | ||
[5] | Topçu M, Aydin O.F, Yalçinkaya C., et al. L-2-hydroxyglutaric aciduria: a report of 29 patients. Turk J. Pediatr 2005; 47: 1-7. | ||
In article | |||
[6] | Moroni I., D’Incerti L., Farina L., et al. Clinical, biochemical and neuroradiological findings in L-2-hydroxyglutaric aciduria. Neurol Sci 2000; 21: 103-8. | ||
In article | View Article PubMed | ||
[7] | Haliloglu G., Jobard F., Oguz K.K, et al. L-2-hydroxyglutaric aciduria and brain tumors in children with mutations in the L2HGDH gene: neuroimaging findings. Neuropediatrics 2008; 39: 119-22. | ||
In article | View Article PubMed | ||
[8] | Latini A., Scussiato K., Borba Rosa R., et al. Induction of oxidative stress by L-2-hydroxyglutaric acid in rat brain. J. Neurosci Res. 2003; 74: 103-110. | ||
In article | View Article PubMed | ||
[9] | Ullah M.I., Nasir A., Ahmad A., et al. Identification of novel L2HGDH mutation in a large consanguineous Pakistani family—a case report. BMC Med. Genet. 2018; 19: 25. | ||
In article | View Article PubMed | ||
[10] | Hanefeld F., Kruse B., Bruhn H. and Frahm J. (1994). In vivo proton magnetic resonance spectroscopy of the brain in a patient with L-2-hydroxyglutaric acidemia. Pediatr. Res., 35, 614-616. | ||
In article | View Article | ||
[11] | Mete A., Isikay S., Sirikci A., et al. Eyelid myoclonia with absence seizures in a child with l-2 hydroxyglutaric aciduria: findings of magnetic resonance imaging. Pediatr Neurol 2012; 46: 195-7. | ||
In article | View Article PubMed | ||
[12] | Topçu M., Erdem G., Saatçi I., et al. Clinical and magnetic resonance imaging features of L-2-hydroxyglutaric acidemia: report of three cases in comparison with Canavan disease. J.Child Neurol 1996; 11: 373-7. | ||
In article | View Article PubMed | ||
[13] | Zafeiriou D.I, Sewellb A., Savvopoulou-Augoustidoua P., Gombakisa N., Katzoset G. L-2-Hydroxyglutaric aciduria presenting as status epilepticus. Brain Dev. 2001; 23(4):255-7. | ||
In article | View Article | ||
[14] | Moroni I., D’Incerti L., Farina L., et al. Clinical, biochemical and neuroradiological findings in L-2-hydroxyglutaric aciduria. Neurol Sci 2000; 21: 103-8. | ||
In article | View Article PubMed | ||
[15] | Karatas H., Saygi S., Bastan B. L-2-hydroxyglutaric aciduria. Report of four Turkish adult patients. Neurologist. 2010; 16: 44-6. | ||
In article | View Article PubMed | ||
[16] | Fujitake J., Ishikawa Y., Fujii H., et al. L-2-hydroxyglutaric aciduria: two Japanese adult cases in one family. J.Neurol 1999; 246: 378-382. | ||
In article | View Article PubMed | ||
[17] | Meral Topçu., Florence Jobard., Sophie Halliez., Turgay Coskun, Cengiz Yalçinkayal, Filiz Ozbas Gerceker, Ronald J.A. Wanders, Jean-François Prud'homme, Mark Lathrop, Meral Özguc, Judith Fischer, L-2-Hydroxyglutaric aciduria: identification of a mutant gene C14orf160, localized on chromosome 14q22.1, Human Molecular Genetics, Volume 13, Issue 22, 15 November 2004, Pages 2803-2811. | ||
In article | View Article PubMed | ||
[18] | Héla Fourati, Emna Ellouze, Mourad Ahmadi, Dhouha Chaari, Fatma Kamoun, Ines Hsairi, Chahnez Triki, Zeineb Mnif, MRI features in 17 patients with l2 hydroxyglutaric aciduria, European Journal of Radiology Open,Volume 3,2016,Pages 245-250, ISSN 2352-0477. | ||
In article | View Article PubMed | ||
[19] | Canda, Ebru & Kose, Melis & Yazıcı, Havva & Er, Esra & Eraslan, Cenk & Ucar, Sema & Habif, Sara & Karaca, Emin & Onay, Hüseyin & Ozkinay, Ferda & Coker, Mahmut. (2018). Clinical, Neuroimaging, And Genetic Features of Patients With L-2-Hydroxyglutaric Aciduria. The Journal of Pediatric Research. 5. 10.4274/jpr.59454. | ||
In article | View Article | ||
[20] | László Sztriha, Aithala Gururaj, Peter Vreken, Michael Nork, Gilles G Lestringant,l-2-hydroxyglutaric aciduria in two siblings,Pediatric Neurology,Volume 27, Issue 2, 2002, Pages 141-144. | ||
In article | View Article | ||
[21] | Aghili 1, Zahedi F, Rafiee E. Hydroxyglutaric aciduria and malignant brain tumor: a case report and literature review. J Neurooncol 2009; 91: 233-6. | ||
In article | View Article PubMed | ||
[22] | Haliloglu G, Jobard F, Oguz KK, et al. L-2-hydroxyglutaric aciduria and brain tumors in children with mutations in the L2HGDH gene: neuroimaging findings. Neuropediatrics 2008; 39: 119-22. | ||
In article | View Article PubMed | ||
[23] | Moroni I, Bugiani M, D’Incerti L, et al. L-2-hydroxyglutaric aciduria and brain malignant tumors: a predisposing condition? Neurology 2004; 62: 1882-4. | ||
In article | View Article PubMed | ||